Medical/Pharmaceuticals

China and India Combat Coronavirus Pandemic Together: Online Ceremony Held for the Handover of Medical Supplies to Aid India

HONG KONG, June 18, 2021 /PRNewswire/ -- On 11 June 2021, an online ceremony was held for the handover of anti-pandemic supplies to aidIndia. Medical supplies toIndia included 135 oxygen concentrators, 5 ventilators and 3,300 KN95 masks. Present at the event were Tang Guocai, Chinese Consul Gener...

2021-06-18 16:15 1927

Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants

MELBOURNE, Australia, June 18, 2021 /PRNewswire/ -- New data released today shows thatAustralia's Viraleze™ anti-COVID nasal spray is more than 99.9% effective against three of the four deadliest variants of the SARS-CoV-2 virus. ...

2021-06-18 14:16 14504

Antengene Provides an Update on Its Latest Developments

* Announces two new in-house discovered assets - ATG-031, a potential first-in-class anti-CD24 monoclonal antibody, and ATG-027, a potential first-in-class B7H3/PD-L1 bi-specific antibody * Provides an update on commercial readiness across the Asia Pacific markets for selinexor, Antengene's f...

2021-06-18 14:10 11947

Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants

MELBOURNE, Australia, June 18, 2021 /PRNewswire/ -- New data released today shows thatAustralia's Viraleze™ anti-COVID nasal spray is more than 99.9% effective against three of the four deadliest variants of the SARS-CoV-2 virus. ...

2021-06-18 14:04 14296

Genesis Rapidly Expands its Surgical Device Portfolio to Meet Growing Demand

SINGAPORE, June 18, 2021 /PRNewswire/ -- Genesis MedTech Group (Genesis) is pleased to announce it has completed the acquisition of Horcon, aChina-based suture company, and secured exclusive distributorship rights for Sejong Medical's trocar products inChina. This comes on the back of its recent ...

2021-06-18 11:33 4578

Gilead Sciences Announces Subanalyses of Safety and Efficacy Data from a Phase 2 Study of Chronic Hepatitis B Patients with Renal or Hepatic Impairment Switching to Vemlidy(r)

HONG KONG, June 18, 2021 /PRNewswire/ -- Gilead Sciences, Inc. today announced new sub-analysis data from a Phase 2 open-label study (GS-US-320-4035; NCT03180619), evaluating the safety and efficacy of switching to Vemlidy®#  (tenofovir alafenamide 25 mg, TAF) from tenofovir disoproxil fumarate (T...

2021-06-18 10:00 2208

Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies

SINGAPORE, June 18, 2021 /PRNewswire/ -- Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion of an oversubscribed$24 million Series A financing round. The round was co-led by EVX Ventures andBoehringer Ingelheim Venture Fun...

2021-06-18 09:58 7355

Jacobio Announces First Two Patients Dosed in SHP2 Combination Study, Triggering US$20 Million Milestone Payment

BEIJING and SHANGHAI and BOSTON, June 18, 2021 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK) has announced that the first two patients have been dosed in the Phase 1/2a clinical trial ofSHP2 inhibitor JAB-3312 in combination with PD-1 antibody Pembrolizumab and MEK inhibitor Binimetinib respe...

2021-06-18 08:31 3518

Innovent Announces First Patient Dosed in the Phase II Basket Trial of Taletrectinib for Solid Tumors with NTRK Fusion

SAN FRANCISCO and SUZHOU, China, June 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...

2021-06-18 08:00 3221

Envirotainer Announces Cathay Pacific as First Asian carrier for the recently released Releye® RLP container

STOCKHOLM, June 17, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that Cathay Pacific has approved the Envirotainer Releye® RLP for carriage on its fleet of aircraft. Cathay Pacific can now off...

2021-06-17 19:49 1516

Eccogene announces the addition of Jacques Mizrahi, PhD to Scientific Advisory Board

SHANGHAI, June 17, 2021 /PRNewswire/ -- Eccogene, Inc., a clinical stage biopharmaceutical company focused on discovery and development of metabolic and immunologic therapeutics, announced today the addition ofJacques Mizrahi, Ph.D., to its scientific advisory board.

2021-06-17 19:49 2187

Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients

ATLANTA, June 17, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its Elekta Harmony* radiation therapy system recently received U.S. FDA 510(k) clearance, paving the way for U.S. clinics to harness the system to treat a comprehensive range of indications using the latest radiotherap...

2021-06-17 14:38 15352

Cigna Survey Confirms Mental Health Services and Support Critical to Global Pandemic Recovery

* Markets with higher COVID-19 vaccination rates report better outlook on health and well-being * Mental health seen as most important influence of whole person health, virtual mental health consultations increased 89 percent since beginning of pandemic * Employees expect more from employer...

2021-06-17 11:38 15097

BitePRO Clothing Aims to Reduce Control and Restraint in Mental Health Care

WETHERBY, England, June 16, 2021 /PRNewswire/ -- According to protective clothing manufacturer,BitePRO , specifically designed protective clothing for health care professionals, as well as patients and service users, will help reduce the use of force within mental health...

2021-06-16 23:07 2887

Gannex Announces Positive Topline Results of the U.S. Phase I Trial of NASH Drug ASC42, an FXR Agonist

SHANGHAI, June 16, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces positive topline results of safety and pharmacodynamic ...

2021-06-16 21:00 3114

Clarivate Report Demonstrates that Nations or Institutions with Diverse Research Priorities Respond More Comprehensively to Unprecedented Scientific Challenges

Forward-looking approach offers a valuable new tool for anticipating and preparing for the unexpected LONDON, June 16, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new Global ...

2021-06-16 15:00 8959

Carepool Asia - Malaysia's first multi-disciplinary digital healthcare platform that offers unlimited telehealth appointments

KUALA LUMPUR, Malaysia, June 16, 2021 /PRNewswire/ -- CAREPOOL ASIA, an innovative digital health platform launches its new, affordable digital health packages, the first telehealth platform that offers unlimited consultation services via a monthly subscription fee, as low asRM170 per month for t...

2021-06-16 12:35 2485

Medidata Becomes First Company to Offer End-to-End, Unified, Secure Platform for Decentralization of Clinical Trials (DCT)

* The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end decentralization for sponsors and CROs * The unique Medidata Trial Dial™ concept provides the industry's highest level of customization for c...

2021-06-16 09:11 2436

Galimedix Accelerating Development of Its Next-Generation Oral Anti-Amyloid Beta Drug GAL-201 for Alzheimer's Disease

Following recent FDA approval of Biogen's Alzheimer antibody drug ADUHELM (TM), targeting oligomers of amyloid beta, Galimedix aims for first patients with its GAL-201 oral small molecule drug within one year. KENSINGTON, Md., June 16, 2021 /PRNewswire/ -- Galimedix, Inc., a clinical-stage bioph...

2021-06-16 04:38 1096

Qynapse to present clinical results of QyScore® for Alzheimer's Disease and Multiple Sclerosis at the 7th Congress of the European Academy of Neurology

BOSTON, June 15, 2021 /PRNewswire/ -- QYNAPSE Inc., a medical technology company commercializing the most advanced artificial intelligence neuroimaging platform, today announced it will present clinical data on QyScore® for Alzheimer's disease and multiple sclerosis at the 7th Congress of the Eur...

2021-06-15 18:00 2272
1 ... 276277278279280281282 ... 397